INT36999

From wiki-pain
Revision as of 23:53, 20 September 2012 by Daniel (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Context Info
Confidence 0.05
First Reported 1986
Last Reported 1986
Negated 0
Speculated 0
Reported most in Abstract
Documents 1
Total Number 3
Disease Relevance 3.46
Pain Relevance 0.91

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (TNFRSF25) signal transduction (TNFRSF25) extracellular region (TNFRSF25)
plasma membrane (TNFRSF25)
HLA-DRB2 (Homo sapiens)
TNFRSF25 (Homo sapiens)
Pain Link Frequency Relevance Heat
Multiple sclerosis 15 98.00 Very High Very High Very High
Neuritis 9 95.44 Very High Very High Very High
Demyelination 9 83.44 Quite High
Disease Link Frequency Relevance Heat
Demyelinating Disease 33 100.00 Very High Very High Very High
Optic Neuritis 9 95.44 Very High Very High Very High
Viral Infection 3 75.00 Quite High
Togavirus Infection 9 65.52 Quite High
Measles 9 64.56 Quite High
Mumps 6 61.68 Quite High
Infection 9 61.20 Quite High
Typhoid Fever 3 57.36 Quite High
Influenza Virus Infection 6 25.00 Low Low
Neurological Disease 3 25.00 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The expected high frequency of HLA-DR2 in patients with demyelinating disease was matched by preselection of normal controls with this antigen (DR2+); the remaining individuals were classified as HLA-DR2 negative/DR3 positive (DR3+) or HLA-DR2 and 3 negative (DR2/3 -).
HLA-DR2 Binding (negative) of DR3 associated with demyelinating disease
1) Confidence 0.05 Published 1986 Journal Brain Section Abstract Doc Link 3456817 Disease Relevance 1.17 Pain Relevance 0.32
The expected high frequency of HLA-DR2 in patients with demyelinating disease was matched by preselection of normal controls with this antigen (DR2+); the remaining individuals were classified as HLA-DR2 negative/DR3 positive (DR3+) or HLA-DR2 and 3 negative (DR2/3 -).
HLA-DR2 Binding (negative) of DR3 associated with demyelinating disease
2) Confidence 0.05 Published 1986 Journal Brain Section Abstract Doc Link 3456817 Disease Relevance 1.14 Pain Relevance 0.30
The expected high frequency of HLA-DR2 in patients with demyelinating disease was matched by preselection of normal controls with this antigen (DR2+); the remaining individuals were classified as HLA-DR2 negative/DR3 positive (DR3+) or HLA-DR2 and 3 negative (DR2/3 -).
HLA-DR2 Binding (negative) of DR3 associated with demyelinating disease
3) Confidence 0.05 Published 1986 Journal Brain Section Abstract Doc Link 3456817 Disease Relevance 1.15 Pain Relevance 0.30

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox